Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Current Opinion in Chemical Biology|February 28, 2015
Targeting carbonic anhydrase IX with small organic ligandsMoreno Wichert, Nikolaus KrallAngewandte Chemie (International Ed. in English)|January 9, 2013
Small targeted cytotoxics: current state and promises from DNA-encoded chemical librariesNikolaus Krall, Jörg Scheuermann, Dario NeriBioconjugate Chemistry|January 29, 2013
Tumor-targeting antibody-anticalin fusion proteins for in vivo pretargeting applicationsMartina Steiner, Katrin Gutbrodt, Nikolaus Krall, et al.Current Opinion in Chemical Biology|February 23, 2020
Patient-derived model systems and the development of next-generation anticancer therapeuticsNikolaus Krall, Giulio Superti-Furga, Gregory I VladimerJournal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 26, 2016
A 99mTc-Labeled Ligand of Carbonic Anhydrase IX Selectively Targets Renal Cell Carcinoma In VivoNikolaus Krall, Francesca Pretto, Martin Mattarella, et al.Nature Chemistry|January 22, 2016
Site-selective protein-modification chemistry for basic biology and drug developmentNikolaus Krall, Filipa P da Cruz, Omar Boutureira, et al.Angewandte Chemie (International Ed. in English)|March 14, 2014
A small-molecule drug conjugate for the treatment of carbonic anhydrase IX expressing tumorsNikolaus Krall, Francesca Pretto, Willy Decurtins, et al.Cancer Research|February 13, 2014
Curative properties of noninternalizing antibody-drug conjugates based on maytansinoidsElena Perrino, Martina Steiner, Nikolaus Krall, et al.Nature Chemistry|February 21, 2015
Dual-display of small molecules enables the discovery of ligand pairs and facilitates affinity maturationMoreno Wichert, Nikolaus Krall, Willy Decurtins, et al.Ebiomedicine|December 27, 2024
Ex vivo imaging-based high content phenotyping of patients with rheumatoid arthritisFelix Kartnig, Michael Bonelli, Ulrich Goldmann, et al.Pageof 2